ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Group Chairs Seek Role Running NCTN

September 12, 2014

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer

August 27, 2010

Funding Opportunity.

July 12, 2002

In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI

February 16, 1990